Atlas Trials

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

Clinical trial NCT00006340 · COMPLETED

Trial details

NCT number
NCT00006340
Sponsor
Boston Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLymphomaPrecancerous ConditionSmall Intestine Cancer
Start date
1994-12-01
Primary completion
2000-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.